Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group

NCT03965598 is registered in ClinicalTrials.gov with Second Xiangya Hospital of Central South University as lead sponsor.

NCT NCT03965598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03965598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group
Lead sponsor
Second Xiangya Hospital of Central South University
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2016
Completion date
December 31, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia